Cartesian Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 16, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	250	461	107	-	-
Market Cap Growth	-43.90%	330.61%	-	-	-
Enterprise Value	103	256	123	-	-
Last Close Price	9.60	17.91	20.68	-	-
PS Ratio	231.24	11.84	4.12	-	-
PB Ratio	-	-67.74	-0.77	-	-
EV/Sales Ratio	100.04	6.58	4.75	-	-
Debt / Equity Ratio	-5.28	-2.06	-0.08	0.40	0.18
Debt / EBITDA Ratio	-	-	-	2.01	-
Asset Turnover	0.00	0.11	0.11	1.26	-
Quick Ratio	13.11	9.29	1.26	5.76	6.38
Current Ratio	13.33	9.43	1.33	5.91	6.42
Return on Equity (ROE)	-	-	-	70.21%	-
Return on Assets (ROA)	-13.65%	-6.00%	-19.75%	10.35%	-
Return on Capital (ROIC)	-	-	-3021.69%	12.98%	-
Return on Capital Employed (ROCE)	-	-	-	10.30%	-
Earnings Yield	-14.53%	-16.80%	-205.34%	-	-
FCF Yield	-17.83%	-7.11%	-48.01%	-	-
Buyback Yield / Dilution	-203.30%	-235.72%	-6.33%	-27.59%	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q